U.S. market Closed. Opens in 11 hours 45 minutes

ATAI | Atai Life Sciences N.V. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue314.00K233.00K20.38MN/AN/A
Cost of Revenue319.00K168.00K47.00K24.00K6.00K
Gross Profit-5.00K65.00K20.33M-24.00K-6.00K
Operating Expenses125.47M144.66M140.70M92.14M8.17M
Selling, General & Admin63.58M70.35M92.75M80.73M5.09M
Research & Development61.88M74.31M47.96M11.41M3.08M
Other Operating Expenses-189.00K9.61M-796.00K-16.09M425.00K
Operating Income-125.47M-144.79M-135.81M-104.16M1.57M
Other Expenses / Income86.18M9.61M-796.00K2.35M-19.05M
Before Tax Income-39.29M-135.18M-136.60M-101.81M-17.47M
Income Tax Expenses1.02M6.23M-3.99M305.00K2.00K
Net Income-40.22M-141.41M-132.61M-102.12M-17.48M
Interest Expenses2.66M1.92MN/AN/AN/A
Basic Shares Outstanding158.83M155.72M160.68M5.81M5.42M
Diluted Shares Outstanding158.83M155.72M160.68M5.81M5.42M
EBITDA-125.15M-144.07M-104.84M-98.47M1.58M
EBITDA Margin-39,857.32%-61,833.91%-514.55%0.00%0.00%
EBIT-36.55M-133.27M-136.60M-101.81M-17.47M
EBIT Margin-11,640.76%-57,196.14%-670.40%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙